Compounds such as Defactinib, GSK2256098, and PF-562271 modulate tumor cell migration, proliferation, invasion, and survival via the FAK/p53 and FAK/RAS/RAF signaling pathways (Figure 2). This evidence concerns the gene PTK2 and neoplasm.